INTRODUCTION
and at the 28th Congress of the Japan Society of Blood Transfusion (Tokyo. 1980 sample. Each rabbit received two im injections of the sample mixed with an equal volume of Freund's complete adjuvant at a one-week interval. Three additional im injections of the sample alone at two-day intervals were given in the fourth week of immunization. Blood samples were collected just before immunization and on immunization days 15, 29 and 41. Sera were tested for antibody titers (as given in Table III ) after being absorbed with group B and o human red cells. Sephadex G-200 gel filtration: A sample of 3.6 ml of 25% HSA or 4.5 ml of 20% HSA was applied to a Sephadex G-200 column (3x95 cm) equilibrated with 0.015 M Tris-buffer (pH 7.2) containing 0.15 M NaCI. The column was eluted with the same buffer at a flow rate of 13.3 ml/hr. Fractions of 4 ml were collected. The protein peaks in the elution profile were identified by comparison with the elution profile of normal human serum applied to an identical column.
Buthanol treatment:
The method cited by Gardas and Koscielak (1971) was followed. Cooled PPF samples were mixed with equal volumes of n-buthanol and vigorously shaken at low temperature. The resultant buthanol and aqueous phases were separately collected. The buthanol phase was evaporated at 37 C. The dry material thus obtained was reconstituted in physiological saline to the original volume of the test material to be determined for blood group activity by HI test. The aqueous phase, without any further treatment, was similarly tested by HI technique.
Extraction with chloroform-methanol: we attempted to extract blood group active principles from a sample of 25% HSA having HI titers of 1:256 for A and 1:128 for B activities. To a 1-ml portion of the sample, 19 ml of chloroform-methanol (2:1) and 4 ml of physiological saline were added. The mixture was vigorously shaken and centrifuged at 3,000 rpm for 10 min. The lower phase was recovered and dried by evaporation. It was reconstituted in 1 ml of physiological saline for determination of blood group activity by HI test. Test for heat-resistance o f the blood group active principle: Another 2-ml aliquot of the test sample used for chloroform-methanol treatment was diluted by adding 40 ml of physiological saline. It was boiled in a water bath for one hour. The supernatant fluid was recovered, concentrated to 2 ml and tested for blood group activity by HI test. Moreover, the boiled and concentrated supernatant fluid was subjected to chloroform extraction (0.5 ml of the sample mixed with 4.5 ml chloroform) on the one hand and to the Sephadex G-200 gel filtration analysis on the other.
RESULTS

Demonstration of A and B Blood Group Activities by Hemagglutination-inhibition Technique
Out of 64 batches of PPF and 31 batches of HSA, only the products from manufacturer A were all found to have A and B blood group activities, whereas all tested batches prepared by other manufacturers were found to be free of blood group activities (Table I) . Their HI titers, shown in Table II , varied from 2 to 16 for A and from 2 to 4 for B in PPF; and 4 to 256 for A and 2 to 128 for B in HSA. In the same test system, our reference material for A and B blood group substances containing 200 pg/ml of each substance inhibited agglutination to the dilution of 1:1,024 in the case of anti-A and to 1:512 in the case of anti-B sera. Thus, the lower limit of detection of our test system is estimated to be 0.2 pg/ml for A substance and 0.4 pg/ml for B substance . Accordingly, the A and B blood group activities of PPF samples must be equivalent to 0.4-3.1 pg/ml and 0.8-1.6 pg/m1, respectively; while these activities of HSA must be equivalent to 0.8-51.2 pg/ml of A and 0.8-25.6 pg/ml of B substances . Table III shows that on immunization day 15, an elevation in anti-A was noticed in three out of four rabbits (Nos. 1, 2 and 4) immunized with PPF showing blood group activities by HI technique . On immunization days 29 and 41, elevation of anti-A titer by four to 32 times was observed in all four rabbits . In contrast, no anti-A response was noted in another group of four rabbits having received PPF samples devoid of blood group activities by HI technique , except for a transient rise (4 to 8) in No. 6 on day 29. Thus, judging from the anti-A response shown in Table III , the in vitro HI test results were in agreement with the in vivo immunogenicity in rabbits.
Anti-A Immune Response in Rabbits
Characterization of Blood Group Active Principle(s) by
Gel Filtration Analysis
When a sample of 25% HSA showing A and B blood group activities by HI technique was subjected to gel filtration through a Sephadex G-200 column , the blood group activity by HI test was found to be localized in earlier fractions (Nos. 46-56), with its peak at Nos. 48-49 (Fig. 1) Test : A twofold dilution series (each 0.25 ml) of rabbit serum was mixed with 0.25 ml of a 2% suspension of group A human red cells in physiological saline . The mixtures were kept at room temperature for 10 min and centrifuged at 1,000 r.p.m. for one minute. The results were read for visible agglutination . ** The number represents the reciprocal of the highest dilution of serum showing visible agglutination. even after being concentrated by five times in protein content. The same pooled fraction gave only a feeble band of precipitation in immunodiflusion against anti-human albumin serum. Thus, it is unlikely that the fraction is composed predominantly of polymerized albumin molecules. On the contrary, no protein peak was observed at the elution site No. 46 to 56 when a negative control (20% HSA in which no blood group A or B activity was demonstrated by HI test) was applied to an identical column (Fig. 2) .
In summary, the sample of HSA having A and B blood group activities formed an additional peak prior to that of albumin itself, and the blood group activity demonstrated by HI test was associated with this earlier peak which must be composed of fraction(s) of larger molecular size than albumin.
Behavior of the Blood Group Active Principle(s) in
Cold Buthanol Treatment By treatment of a PPF sample showing A and B blood group activities with an equal volume of chilled n-buthanol, the blood group activity in HI test was recovered in the aqueous phase alone. When the same treatment was applied to a negative control without blood group activity in HI test, neither blood group A nor B activity was observed in either of the two phases. ABO 
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Heat-resistance of the Blood Group Active Principle(s) and Failure of Its Extraction with Chloroform or Chloroform-methanol Our attempt to extract blood group active principles(s) with chloroformmethanol was not met with success. Neither blood group A nor B activity could be definitely demonstrated in the extract of the HSA sample used in this experiment.
When the same HSA diluted to a protein content of approximately 6 mg/ml was boiled for one hour, the supernatant fluid was found to have retained most of the blood group activity, yielding activities of 1:128 for A and 1:64 for B. By chloroform treatment of the boiled test material, all blood group activity was recovered in the aqueous phase with HI titers of 1:128 for A and 1:64 for B, leaving no activity in the chloroform phase. When the same boiled material was concentrated and applied to a Sephadex G-200 column, the blood group activity was again demonstrated at the site where the activity of the original test material was found to be localized, that is, corresponding to fraction Nos. 46 to 56 in Fig. 1 .
Thus, the blood group active principle(s), or at least a significant part thereof, was demonstrated to be thermostable and non-extractable with organic solvents such as chloroform or chloroform-methanol.
DISCUSSION
In this study, all tested batches of PPF and HSA prepared by manufacture A during the period from 1975 to 1978 were found to have blood group A and B activities. Although we are not certain if A and B active substances were present as mutually independent entities and no test for H activity has yet been undertaken, it can still be said that either A and B activities or an activity covering both specificities was demonstrated in the test samples by HI test.
Our reference material for A and B blood group activities was calibrated against the Bureau of Biologics Reference Blood Group Substances which is regarded as the best quantitated reference material so far available (Guencheva and Manolova, 1979; Knoop, 1974) . The sensitivity of our HI test was thereby estimated to be approximately 0.2 pg/ml for A and 0.4 pg/ml for B activities, which did not greatly dialer from the values given by Knoop (1974) : 0.08 pg/ml for A and 0.7 pg/ml for B substances. With some PPF samples, the presence of blood group A activity was further confirmed by their elicitation of anti-A response in rabbits.
Thus, anti-A or anti-B response in patients administered some batches of PPF, as was reported by Okochi and his co-workers (Kiyokawa et al., 1978; Matsuo and Okochi, 1975; Okochi, 1975) , can be explained by assuming alloantigenicity of the blood group active principles contained therein. Later, it was disclosed that manufacturer A had been using a mixture of venous blood and placentae as the source material for their albumin preparations. YASUDA et al. Vol. 34 Concerning the possible origin of blood group activities in plasma protein products, the assumption of Dauber et al. (1970) that the overwhelming source must be the erythrocytes hemolyzed by freezing placentae has been generally accepted (Knoop and Johannsen, 1974; Plan et al., 1974) . ABH blood group substances are known to occur normally in human plasma as glycosphingolipids (Mollison, 1979; Tilley et al., 1975) . In red cell membranes, the major part of ABH blood group substances is of glycosphingolipid nature , although glycoprotein type also occur in red cells of ABH secretors (Gardas and Koscielak, 1971) . Thus, if a large amount of glycolipid blood group substances could be detected in albumin preparations, it can naturally be assumed to have been derived from red cells. This was not the case in our test samples in which blood group activity was recovered only in the aqueous phase following buthanol treatment at reduced temperature. Although the interpretation of the results of buthanol extraction of erythrocytes is somewhat contradictory among different authors (Mehta, 1980) , we know as yet no better means of distinguishing between glycolipid and glycoprotein blood group substances in plasma or in plasma protein products. Also, we are aware of the difficulty of demonstrating blood group activity in crude buthanol extracts (Gardas and Kocielak, 1971 ), but its existence in the aqueous phase can not be denied either . Other findings, such as resistance to heating, failure of extraction with chloroform or chloroform-methanol, or localization of blood group activities in earlier fractions in Sephadex G-200 gel permeation analysis, do not seem to disprove the glycoprotein nature of the blood group active principles in our test samples .
So, if the blood group active principles originate from erythrocytes as assumed by Dauber et al. (1970) , the glycolipid moiety must have been removed in ethanol fractionation processes leaving only glycoproteins in the final products . Alternatively, it is also feasible that blood group active principles of glycoprotein nature could have been derived from sources other than red cells , such as secretion adsorbed by the placenta at delivery.
Von Oettingen and Witebsky (1928) were the first to test placental tissues for their distribution of blood group activities. They found that most placental tissues, except deciduae, were free of alcohol-soluble blood group antigens . Subsequent investigators, however, were able to demonstrate some kind of ABO antigens in human placenta and amniotic fluid (Freda , 1958; Schultze-Mosgau and Fischer, 1973) .
Thus far, our work raises the question as to the origin of blood group active principles in placental albumin preparations by demonstrating characteristics which favor their glycoprotein rather than glycolipid nature .
